Table 2.
Genetic association of diseases/traits and corresponding genes
Term | Count | p value | Genes |
---|---|---|---|
Diabetes, type 2 | 18 | 3.82E–06 | SREBF1, HNF1B, KIF11, WFS1, LEPR, PPARG, IDE, FTO, IGF2BP2, CDKAL1, KCNJ11, TCF7L2, CRHR2, HNF4A, SLC2A2, GIPR, SLC30A8, ABCC8 |
Obesity | 7 | 1.91E–02 | SREBF1, CRHR2, GCKR, LEPR, FTO, PPARG, MC4R |
Insulin | 6 | 8.78E–04 | LEPR, PPARG, IDE, KCNJ11, ABCC8, TCF7L2 |
Diabetes, gestational | 5 | 5.79E–04 | HNF4A, PPARG, KCNJ11, ABCC8, TCF7L2 |
Psoriasis | 5 | 2.85E–02 | GSTM1, CCHCR1, POU5F1, ZNF148, PPARG |
Diabetes, type 2 triglycerides | 3 | 5.97E–03 | IGF2BP2, CDKAL1, SLC30A8 |
Laryngeal cancer | 3 | 1.24E–02 | GSTM1, CCND1, BCL2 |
Binge eating | 2 | 3.47E–02 | LEPR, MC4R |
Diabetes, type 2 glucose insulin | 2 | 3.47E–02 | HNF4A, TCF7L2 |
The significant diseases (p < 0.05) are listed and sorted by the count of enriched pleiotropic genes. The corresponding p values and the specific genes are shown in the third and fourth columns. The pleiotropic genes are enriched in two major diseases: diabetes and obesity. Some genes such as “SREBF1,” “CRHR2,” “LEPR,” “FTO,” and “PPARG” are involved in both diseases